TRP Stock Overview
A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Tissue Repair Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.26 |
| 52 Week High | AU$0.49 |
| 52 Week Low | AU$0.20 |
| Beta | 0.48 |
| 11 Month Change | -23.88% |
| 3 Month Change | -32.00% |
| 1 Year Change | 6.25% |
| 33 Year Change | -52.34% |
| 5 Year Change | n/a |
| Change since IPO | -63.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| TRP | AU Biotechs | AU Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | 0.9% |
| 1Y | 6.3% | 11.0% | 18.4% |
Return vs Industry: TRP underperformed the Australian Biotechs industry which returned 11% over the past year.
Return vs Market: TRP underperformed the Australian Market which returned 18.4% over the past year.
Price Volatility
| TRP volatility | |
|---|---|
| TRP Average Weekly Movement | 10.3% |
| Biotechs Industry Average Movement | 9.8% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: TRP has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: TRP's weekly volatility has decreased from 22% to 10% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Tony Charara | tissuerepair.com.au |
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures. The company was incorporated in 2012 and is based in Sydney, Australia.
Tissue Repair Ltd Fundamentals Summary
| TRP fundamental statistics | |
|---|---|
| Market cap | AU$15.72m |
| Earnings (TTM) | -AU$4.14m |
| Revenue (TTM) | AU$1.79m |
8.8x
P/S Ratio-3.8x
P/E RatioIs TRP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRP income statement (TTM) | |
|---|---|
| Revenue | AU$1.79m |
| Cost of Revenue | AU$0 |
| Gross Profit | AU$1.79m |
| Other Expenses | AU$5.93m |
| Earnings | -AU$4.14m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.068 |
| Gross Margin | 100.00% |
| Net Profit Margin | -231.07% |
| Debt/Equity Ratio | 0% |
How did TRP perform over the long term?
See historical performance and comparison